We are live on ! Find out more
LMR Partners

LMR Partners Portfolio holdings

AUM $32.6B Turnover 45.82%
1-Year Est. Return 45.61%
 

LMR Partners is a British multi-strategy investment firm named after its three founders, Ben Levine, Andrew Manuel and Stefan Renold, whose surname initials spell LMR. All three had been traders at UBS and Goldman Sachs, and Paloma Partners provided seed money before the firm began trading in 2010. Manuel left in 2015 and launched Ixworth Capital, his own global macro hedge fund. The firm focuses on global macro and event-driven strategies, mixing computer-model trading with trades chosen by its portfolio managers.

This Fund
S&P 500
This Quarter Est. Return
+4.46%
1 Year Est. Return
+45.61%
3 Year Est. Return
+238.3%
5 Year Est. Return
+283.63%
10 Year Est. Return
+733.38%
AUM
$32.6B
AUM Growth
+$5.8B
Cap. Flow
-$2.24B
Cap. Flow %
-6.88%
Top 10 Hldgs %
23.21%
Holding
1,999
New
513
Increased
354
Reduced
302
Closed
403
Avg Time Held Equity + Options
0.7 years
Top 10 Avg Time Held Equity + Options
0.2 years
Top 20 Avg Time Held Equity + Options
0.4 years
Avg Time Held Equity only
0.7 years
Top 10 Avg Time Held Equity only
0.5 years
Top 20 Avg Time Held Equity only
0.6 years

Top Buys

Rank Stock Value
1
LNTH icon
Lantheus
LNTH
+$215M
2
NVS icon
Novartis
NVS
+$116M
3
LITE icon
Lumentum
LITE
+$91.8M
4
MDT icon
Medtronic
MDT
+$90.8M
5
SHOP icon
Shopify
SHOP
+$88.5M

Sector Composition

Rank Sector Weight
1 Miscellaneous 74.57%
2 Technology 7.25%
3 Healthcare 5.19%
4 Communication Services 3.16%
5 Financials 2.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ILLUU icon
426
Illumination Acquisition Corp I Units
ILLUU
$10.3M 0.03%
1,000,000
– –
2026 Q1
2 quarters
CXII icon
427
Churchill Capital Corp XII
CXII
$577M
$10.3M 0.03%
950,000
+200,000
+27% +$2.15M
2026 Q2
1 quarter
IONS icon
428
Ionis Pharmaceuticals
IONS
$4.56B
$10.2M 0.03%
229,249
+198,449
+644% +$11.3M
2025 Q3
4 quarters
DLTR icon
429
Dollar Tree
DLTR
$26.7B
$10.2M 0.03%
89,500
+9,500
+12% +$1.18M
2026 Q2
1 quarter
ACAAU icon
430
Averin Capital Acquisition Corp Units
ACAAU
$10.2M 0.03%
1,000,000
– –
2026 Q1
2 quarters
LPCVU icon
431
Launchpad Cadenza Acquisition Corp I Unit
LPCVU
$10.1M 0.03%
1,000,000
– –
2025 Q4
3 quarters
MESH icon
432
Meshflow Acquisition Corp
MESH
$437M
$10.1M 0.03%
+1,000,000
New +$10M
2026 Q3
0 quarters
PCG icon
433
PG&E
PCG
$30.2B
$10.1M 0.03%
+823,500
New +$13.2M
2026 Q3
0 quarters
HUT icon
434
CALL
Hut 8
HUT
$6.86B
$10.1M 0.03%
+116,800
New +$11.1M
2026 Q3
0 quarters
PTACU icon
435
Patriot Acquisition Corp Units
PTACU
$205M
$10M 0.03%
1,000,000
– –
2026 Q2
1 quarter
MRCOU icon
436
Mercator Acquisition Corp Units
MRCOU
$10M 0.03%
+1,000,000
New +$10M
2026 Q3
0 quarters
GLED.U icon
437
GalaxyEdge Acquisition Corp Units
GLED.U
$10M 0.03%
980,000
– –
2026 Q1
2 quarters
BIDWU
438
Tribeca Strategic Acquisition Corp Unit
BIDWU
$145M
$10M 0.03%
1,000,000
– –
2026 Q2
1 quarter
MCD icon
439
McDonald's
MCD
$193B
$10M 0.03%
43,317
-8,236
-16% -$2.17M
2025 Q1
6 quarters
TBCVU icon
440
Thunder Bridge Capital Partners V Units
TBCVU
$10M 0.03%
+1,000,000
New +$9.9M
2026 Q3
0 quarters
VII.U
441
Viking Acquisition Corp II Units
VII.U
$9.9M 0.03%
+1,000,000
New +$10M
2026 Q3
0 quarters
ARXS icon
442
Arxis
ARXS
$23B
$9.9M 0.03%
200,700
– –
2026 Q2
1 quarter
KVUE icon
443
DELISTED
Kenvue
KVUE
$9.9M 0.03%
560,108
-945,357
-63% -$17.8M
2025 Q3
4 quarters
CNQ icon
444
CALL
Canadian Natural Resources
CNQ
$92.7B
$9.9M 0.03%
+210,000
New +$9.9M
2026 Q3
0 quarters
WDC icon
445
PUT
Western Digital
WDC
$108B
$9.8M 0.03%
21,600
+1,600
+8% +$778K
2026 Q2
1 quarter
NU icon
446
CALL
Nu Holdings
NU
$58.4B
$9.8M 0.03%
+775,000
New +$11M
2026 Q3
0 quarters
BE icon
447
CALL
Bloom Energy
BE
$50.6B
$9.7M 0.03%
+35,000
New +$8.27M
2026 Q3
0 quarters
DRTSW icon
448
Alpha Tau Medical Warrant
DRTSW
$42.6M
$9.7M 0.03%
2,366,823
+872,192
+58% +$3.2M
2024 Q4
7 quarters
JAZZ icon
449
Jazz Pharmaceuticals
JAZZ
$15.9B
$9.7M 0.03%
+41,740
New +$10.3M
2026 Q3
0 quarters
SWKS icon
450
Skyworks Solutions
SWKS
$19.4B
$9.6M 0.03%
+111,962
New +$7.89M
2026 Q3
0 quarters

Similar funds

LMR Partners's Q3 2026 Portfolio in Review

As of Q3 2026, LMR Partners held 1,999 positions worth $32.6B, up 22% from $26.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

LMR Partners withdrew a net $2.24B in Q3 2026, closing 403 positions and reducing 302 holdings. Its most notable exit was Chart Industries, an estimated $109M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 75% of assets, up from 71% a quarter earlier, followed by Technology and Healthcare.

Against the trend, LMR Partners opened a new position in Lantheus worth $210M.

  • LMR Partners's largest Q3 2026 buy was Lantheus: 2,108,000 shares worth $210M.
  • LMR Partners added most to Novartis in Q3 2026, an estimated $116M increase.
  • LMR Partners's biggest Q3 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $632M.
  • LMR Partners fully exited Chart Industries in Q3 2026, selling an estimated $109M.
  • LMR Partners's ten largest holdings make up 23% of its $32.6B portfolio in Q3 2026.
  • LMR Partners opened 513 new positions and closed 403 in Q3 2026.
  • LMR Partners's portfolio value rose 22% quarter-over-quarter to $32.6B.

Based on LMR Partners's 13F filing for Q3 2026, filed 16 Nov 2026.